Expired activity
Please go to the PowerPak homepage and select a course.

Non-tuberculous Mycobacterial Lung Disease (NTM-LD): New Guidelines to Manage a Challenging Respiratory Disease

This continuing pharmacy educational activity is provided by Vindico Medical Education and supported by an educational grant from Insmed Incorporated.


May 31, 2021


May 30, 2022

Activity Chair

David E. Griffith, MD, FACP, FCCP, ATSF
Professor of Medicine
National Jewish Health
Denver, CO

Consulting Fee: Insmed
Speakers Bureau: Insmed
Non-CME Service Fees: Insmed
Contracted Research: Insmed


Charles L. Daley, MD
Professor of Medicine
National Jewish Health and University of Colorado
Chief, Division of Mycobacterial and Respiratory Infections
National Jewish Health
Denver, CO

Consulting Fee: AN2, Cipla, Insmed, Matinas, Paratek, Spero
Contracted Research: Insmed

Kevin Winthrop, MD, MPH
Professor, Division of Infectious Diseases
Schools of Medicine and Public Health
Oregon Health and Sciences University
Portland, OR

Consulting Fee: Horizon, Insmed, Paratek, Red Hill Biopharma, Spero
Contracted Research: Insmed

Medical Writer

Valerie Zimmerman, PhD
Disclosure: No relevant financial relationships to disclose.


Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Disclosure: No relevant financial relationships to disclose.

Jennifer Frederick, PharmD, BCPS
Disclosure: No relevant financial relationships to disclose.

Linda A. Giarraputo, PA-C
Disclosure: No relevant financial relationships to disclose.

Target Audience

The intended audience for this activity is infectious disease specialists, pulmonologists, pharmacists, nurse practitioners, physician assistants, and other health care professionals involved in the management of patients with non-tuberculous mycobacterial lung disease.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Identify patients with non-tuberculous mycobacterial lung disease (NTM-LD) using knowledge of pathophysiology; environmental factors; underlying conditions (eg, bronchiectasis); and risk factors.
  • Review the newly updated guideline recommendations for the diagnosis and treatment of NTM-LD.
  • Examine the strategies to manage adverse effects associated with treatment of NTM-LD including approaches to improve treatment adherence.

Accreditation Statement

acpeVindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Credit Designation

This program is acceptable for 1.0 contact hour of ACPE Continuing Education Credit. The ACPE Universal Program Number 0482-0000-21-009-H01-P, effective 5/31/2021. This is a knowledge-based activity, and there is no fee to attend.

This enduring material is approved for 1 year from the date of original release, May 31, 2021, through May 30, 2022.

How to Participate in This Activity and Obtain CME Credit

To participate in this CPE activity, you must read the objectives, answer the pretest questions, view the CPE content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue a ACPE Statement of Credit. Vindico Medical Education will provide pharmacist credits claimed information directly to the ACPE through CPE Monitor.


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, faculty, and reviewers involved in the development of accredited content. Individuals have a relevant financial relationship if they have a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information is accurate at the time of content development.

The articles in this monograph were composed by Medical Writer Valerie Zimmerman, PhD, based on the presentations of Drs. Griffith, Daley, and Winthrop during a virtual expert panel discussion held on March 5, 2021. The monograph has been approved by each of the faculty individually as an accurate representation of their presentations.

Vindico Medical Education staff have no relevant financial relationships to disclose.

Signed Disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at cme@vindicoCME.com